PolyPid Ltd.(PYPD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PYPD PolyPid Ltd.

Closed 02-23 16:00:00 EST

4.24

+0.06

+1.44%

盘后4.24

+0.000.00%

19:41 EST

High4.28	Low4.18	Vol40.87K
Open4.18	D1 Closing4.18	Amplitude2.27%
Mkt Cap77.18M	Tradable Cap43.44M	Total Shares18.20M
T/O173.00K	T/O Rate0.40%	Tradable Shares10.25M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PYPD","market":"US","secType":"STK","nameCN":"PolyPid Ltd.","latestPrice":4.24,"timestamp":1771880400000,"preClose":4.18,"halted":0,"volume":40871,"hourTrading":{"tag":"盘后","latestPrice":4.24,"preClose":4.24,"latestTime":"19:41 EST","volume":30,"amount":125.84,"timestamp":1771893675454,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.014354066985646053,"floatShares":10245500,"shares":18204002,"eps":-2.09,"marketStatus":"Closed","change":0.06,"latestTime":"02-23 16:00:00 EST","open":4.18,"high":4.275,"low":4.18,"amount":172996.7048145,"amplitude":0.022727,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.09,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771923600000},"marketStatusCode":5,"adr":0,"listingDate":1593144000000,"exchange":"NASDAQ","adjPreClose":4.18,"postHourTrading":{"tag":"盘后","latestPrice":4.24,"preClose":4.24,"latestTime":"19:41 EST","volume":30,"amount":125.84,"timestamp":1771893675454,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.946399,"impliedVol":0.4723,"impliedVolPercentile":0.0909},"requestUrl":"/m/hq/s/PYPD/wiki","defaultTab":"wiki","newsList":[{"id":"2611163468","title":"Analysts Are Bullish on Top Healthcare Stocks: PolyPid (PYPD), Dexcom (DXCM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2611163468","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611163468?lang=en_us&edition=fundamental","pubTime":"2026-02-13 22:31","pubTimestamp":1770993076,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on PolyPid (PYPD – Research Report), Dexcom (DXCM – Res...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-polypid-pypd-dexcom-dxcm-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-polypid-pypd-dexcom-dxcm-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0266013472.USD","LU0354030511.USD","BLSX","BK4581","LU2210149790.SGD","LU2095319765.USD","XBI","BK4007","LABU","LU0029874061.USD","BK4137","BLSG","IE00BMPRXR70.SGD","LU2433249047.HKD","BK4585","BK4534","IE00BMPRXN33.USD","PYPD","BK4548","LU0354030438.USD","BK4082","BK4551","DXCM","BK4504","LU2125909247.SGD","LU1923622614.USD","BK4112","LU1323610961.USD","LU2125909593.SGD","LU0128526141.USD","LU2211815571.USD","LU2210150020.SGD","BK4588"],"gpt_icon":0},{"id":"2610998962","title":"PolyPid Earnings Call Flags Big 2026 Catalyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2610998962","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610998962?lang=en_us&edition=fundamental","pubTime":"2026-02-12 08:19","pubTimestamp":1770855570,"startTime":"0","endTime":"0","summary":"PolyPid Ltd. (($PYPD)) has held its Q4 earnings call. Read on for the main highlights of the call. PolyPid’s latest earnings call struck an upbeat ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/polypid-earnings-call-flags-big-2026-catalyst?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/polypid-earnings-call-flags-big-2026-catalyst?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYPD"],"gpt_icon":0},{"id":"2610950036","title":"PolyPid Price Target Maintained With a $13.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2610950036","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610950036?lang=en_us&edition=fundamental","pubTime":"2026-02-12 02:26","pubTimestamp":1770834360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PYPD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 11, 2026 13:26 ET (18:26 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD"],"gpt_icon":0},{"id":"2610973954","title":"PolyPid: Advancing D-PLEX100 De-Risks Platform Potential and Creates Compelling Buy-Rated Risk-Reward","url":"https://stock-news.laohu8.com/highlight/detail?id=2610973954","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610973954?lang=en_us&edition=fundamental","pubTime":"2026-02-12 00:05","pubTimestamp":1770825935,"startTime":"0","endTime":"0","summary":"In a report released today, Brandon Folkes from H.C. Wainwright reiterated a Buy rating on PolyPid, with a price target of $13.00. Brandon Folkes h...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/polypid-advancing-d-plex100-de-risks-platform-potential-and-creates-compelling-buy-rated-risk-reward-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/polypid-advancing-d-plex100-de-risks-platform-potential-and-creates-compelling-buy-rated-risk-reward-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PYPD"],"gpt_icon":0},{"id":"2610932012","title":"Israel's PolyPid Q4 EPS improves on lower R&D expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2610932012","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610932012?lang=en_us&edition=fundamental","pubTime":"2026-02-11 20:38","pubTimestamp":1770813539,"startTime":"0","endTime":"0","summary":"Israel's PolyPid Q4 EPS improves on lower R&D expensesOverviewIsrael biopharmaceutical firm's Q4 net loss was $8.5 mln, with improved loss per shareR&D expenses decreased due to completion of SHIELD I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nL1N3Z70LR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PYPD"],"gpt_icon":0},{"id":"2610932223","title":"BRIEF-PolyPid Q4 Net Income USD -8.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2610932223","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610932223?lang=en_us&edition=fundamental","pubTime":"2026-02-11 20:30","pubTimestamp":1770813046,"startTime":"0","endTime":"0","summary":"BRIEF-PolyPid Q4 Net Income USD -8.5 Million\n\n\nFeb 11 (Reuters) - PolyPid Q4 EPS USD -0.41.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nPLX1C4134:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PYPD"],"gpt_icon":0},{"id":"2610932276","title":"PolyPid posts FY2025 net loss of USD 8.47 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2610932276","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610932276?lang=en_us&edition=fundamental","pubTime":"2026-02-11 20:30","pubTimestamp":1770813042,"startTime":"0","endTime":"0","summary":"PolyPid Ltd. reported its financial results for the fourth quarter  and full year  ended December 31, 2025. For FY 2025, the company reported a net loss attributable to ordinary shares of USD 8.47 million. The loss per share for the period was USD 0.41, based on a weighted average of 20,588,114 ordinary shares. In Q4 2025, PolyPid recorded an operating loss of USD 8.53 million and a net financial expense of USD 24 thousand. The company also posted a loss before income tax of USD 8.55 million for the full year. General and administrative expenses for FY 2025 amounted to USD 1.76 million, while marketing and business development expenses were USD 556 thousand. On the business front, PolyPid is in advanced discussions regarding a commercial U.S. partnership for its lead product, D-PLEX100. The company received positive FDA pre-NDA feedback supporting a rolling NDA review, with the submission expected to begin by the end of the first quarter of 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDL902QCw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","IE00B64PRP62.GBP","SG9999014013.SGD","BK4112","IE00BGHQF748.EUR","NDAQ","BK4585","LU2210150020.SGD","PYPD","BK4588","SG9999014005.SGD","SG9999014039.USD","LU2210149790.SGD","LU0314104364.USD","SG9999014021.USD","IE00B3QW5Z07.USD","BK4007","LU2095319765.USD"],"gpt_icon":0},{"id":"2610200932","title":"PolyPid Q4 EPS $(0.41) Misses $(0.34) Estimate.","url":"https://stock-news.laohu8.com/highlight/detail?id=2610200932","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610200932?lang=en_us&edition=fundamental","pubTime":"2026-02-11 20:30","pubTimestamp":1770813041,"startTime":"0","endTime":"0","summary":"PolyPid (NASDAQ:PYPD) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.34) by 21.66 percent. This is a 63.72 percent increase over losses of $(1.13) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50537532/polypid-q4-eps-0-41-misses-0-34-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD"],"gpt_icon":0},{"id":"2610932246","title":"PolyPid Q4 EPS USD -0.41","url":"https://stock-news.laohu8.com/highlight/detail?id=2610932246","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610932246?lang=en_us&edition=fundamental","pubTime":"2026-02-11 20:30","pubTimestamp":1770813001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nPLX1C4134:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PYPD"],"gpt_icon":0},{"id":"2610260932","title":"Press Release: PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2610260932","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610260932?lang=en_us&edition=fundamental","pubTime":"2026-02-11 20:30","pubTimestamp":1770813000,"startTime":"0","endTime":"0","summary":"The Company is in Advanced Stages of Commercial U.S. Partnership Discussions for D-PLEX. Positive FDA Pre-NDA Feedback Supports Rolling NDA Review; Submission Expected to Begin by the End of the First Quarter of 2026. PETACH TIKVA, Israel, Feb. 11, 2026  -- PolyPid Ltd.  , an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment effectiveness, right where care begins, today provided a corporate update and reported financial results for the three months and full year ended December 31, 2025.-- Advancing Toward Commercialization: The Company made significant progress. towards finalizing a potential partnership in the United States for. -- Regulatory Momentum: Received positive feedback from the U.S. Food and.  meeting minutes for D-PLEX in the prevention of abdominal. colorectal surgical site infections  for a planned rolling NDA. 11, 2025. Ms. Story brings extensive leadership experience in medical. FRCS , MAMSE, Executive Director and Syste","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["X","TM","PYPD","BK4555","BK4604","BK4520","BK4516","BK4006","BK4007","BK4585","03160","BK4588","BK4099"],"gpt_icon":0},{"id":"2610375936","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2610375936","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610375936?lang=en_us&edition=fundamental","pubTime":"2026-02-11 19:00","pubTimestamp":1770807600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·FLEX LNG Ltd                                    4Q       .43   1:00 AM","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLBT","FSLY","AVTR","HUM","AMCX","CGNX","CFLT","FCPT","INSP","GNRC","CIM","AUR","EQIX","FAF","HUBS","FBRT","FLNG","DDI","BWA","GFS","AGIO","CRTO","GPMT","CSCO","INTR","CXT","APP","KHC","CW","CPA","AR","BXMT","IRT","DAR","GRAB","AEE","IFF","CXW","GFL","AM","EPRT","AMG","CRK","CHEF","ASND","PYPD","HLT","ALB","MCD","GTY"],"gpt_icon":0},{"id":"2609187373","title":"PolyPid Ltd. Held Extraordinary General Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2609187373","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609187373?lang=en_us&edition=fundamental","pubTime":"2026-02-05 05:09","pubTimestamp":1770239376,"startTime":"0","endTime":"0","summary":"PolyPid Ltd. held an Extraordinary General Meeting of Shareholders on February 4, 2026. The meeting included a proposal to approve the compensation terms of Brooke Story, the chairman of the board of directors. The proposal was approved by the shareholders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PolyPid Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 04, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL68k0hc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD","BK4007"],"gpt_icon":0},{"id":"2606719062","title":"PolyPid to Report Fourth Quarter 2025 Financial Results and Operational Highlights on February 11, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2606719062","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606719062?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:00","pubTimestamp":1769605200,"startTime":"0","endTime":"0","summary":"PETACH TIKVA, Israel, Jan.  28, 2026  (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (\"PolyPid\" or the \"Company\"), a late-stage biopharma company aiming to improve surgical outcomes, today announced ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/28/3227536/0/en/PolyPid-to-Report-Fourth-Quarter-2025-Financial-Results-and-Operational-Highlights-on-February-11-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","BK4588","PYPD","BK4520","BK4585","BK4007","X","BK4516"],"gpt_icon":0},{"id":"2600709776","title":"PolyPid Ltd. Shareholders to Vote on Compensation Terms for Board Chairman at Upcoming Extraordinary Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2600709776","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600709776?lang=en_us&edition=fundamental","pubTime":"2026-01-01 05:01","pubTimestamp":1767214913,"startTime":"0","endTime":"0","summary":"PolyPid Ltd. has scheduled an Extraordinary General Meeting of shareholders for February 4, 2026, where shareholders will vote on a proposal to approve the compensation terms of Ms. Brooke Story, chairman of the company's board of directors. The Board of Directors recommends voting in favor of the proposal.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PolyPid Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 31, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nNDLf1KzB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PYPD"],"gpt_icon":0},{"id":"2591878939","title":"Press Release: PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2591878939","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591878939?lang=en_us&edition=fundamental","pubTime":"2025-12-16 21:30","pubTimestamp":1765891800,"startTime":"0","endTime":"0","summary":"PETACH TIKVA, Israel, Dec. 16, 2025  -- PolyPid Ltd.  , a late-stage biopharma company aiming to improve surgical outcomes, today announced the appointment of Brooke Story as Chairman of the Board of Directors, effective as of December 11, 2025.\"Brooke's appointment marks an exciting and pivotal moment for PolyPid,\" said Dikla Czaczkes Akselbrad, Chief Executive Officer of PolyPid. \"Her global expertise in the surgical market, specifically in infection prevention and advanced surgical solutions, combined with her extensive experience leading corporate strategy and corporate development transactions, will be instrumental in transforming our clinical success into a commercial reality.\". \"I am honored to join PolyPid at this pivotal stage in the Company's development,\" said Ms. Story. \"I look forward to supporting the team as it leverages its delivery platform to address critical, high-cost needs in surgical infection prevention, creating a clear opportunity to build significant enterpris","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD","BK4007","BK4520","BK4006","BK4588","X","BK4516","BK4585"],"gpt_icon":0},{"id":"2588041874","title":"BRIEF-Polypid Announces Positive FDA Pre-NDA Meeting Minutes","url":"https://stock-news.laohu8.com/highlight/detail?id=2588041874","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588041874?lang=en_us&edition=fundamental","pubTime":"2025-12-03 21:33","pubTimestamp":1764768830,"startTime":"0","endTime":"0","summary":"BRIEF-Polypid Announces Positive FDA Pre-NDA Meeting Minutes Dec 3 (Reuters) - PolyPid Ltd PYPD.O:POLYPID ANNOUNCES POSITIVE FDA PRE-NDA MEETING MINUTES FOR D-PLEX SUPPORTING NDA SUBMISSIONPOLYPID LTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nTUA6P3VSM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD","BK4007"],"gpt_icon":0},{"id":"2588490090","title":"PolyPid Ltd - FDA Agreed to a Rolling Nda Review, Allowing PolyPid to Submit First Completed Sections in Early 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2588490090","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588490090?lang=en_us&edition=fundamental","pubTime":"2025-12-03 21:30","pubTimestamp":1764768600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nTUA6P3VSM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PYPD","BK4007"],"gpt_icon":0},{"id":"2588049727","title":"PolyPid Announces Positive FDA Pre-Nda Meeting Minutes for D-Plex₁₀₀ Supporting Nda Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2588049727","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588049727?lang=en_us&edition=fundamental","pubTime":"2025-12-03 21:30","pubTimestamp":1764768600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nTUA6P3VSM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PYPD"],"gpt_icon":0},{"id":"2586298185","title":"PolyPid Expands Share Offering to Strengthen Financial Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2586298185","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586298185?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:29","pubTimestamp":1764192585,"startTime":"0","endTime":"0","summary":"PolyPid ( ($PYPD) ) just unveiled an announcement. On November 26, 2025, PolyPid Ltd. announced an increase in the maximum aggregate offering price...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/polypid-expands-share-offering-to-strengthen-financial-position?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/polypid-expands-share-offering-to-strengthen-financial-position?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYPD","BK4007"],"gpt_icon":0},{"id":"2586458476","title":"PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2586458476","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586458476?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:30","pubTimestamp":1764077400,"startTime":"0","endTime":"0","summary":"Internationally recognized colorectal surgeon Steven D. Wexner, MD, FACS, FRCS, to discuss the clinical and economic burden of surgical site infections and the therapeutic potential of D-PLEXPETACH TI","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/25/3194326/0/en/PolyPid-to-Participate-in-ROTH-Capital-Partners-Virtual-KOL-Event-on-December-10-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ROTH","BK4588","BK4516","PYPD","BK4585","BK4520","X","KOL","BK4006"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.polypid.com","stockEarnings":[{"period":"1week","weight":-0.0564},{"period":"1month","weight":-0.0893},{"period":"3month","weight":0.1611},{"period":"6month","weight":0.1943},{"period":"1year","weight":0.3933},{"period":"ytd","weight":-0.0369}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.080091},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.023408},{"month":3,"riseRate":0.2,"avgChangeRate":-0.088788},{"month":4,"riseRate":0.6,"avgChangeRate":-0.021004},{"month":5,"riseRate":0.4,"avgChangeRate":-0.000865},{"month":6,"riseRate":0.2,"avgChangeRate":-0.006444},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.076054},{"month":8,"riseRate":0.333333,"avgChangeRate":0.004327},{"month":9,"riseRate":0,"avgChangeRate":-0.267226},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.05946},{"month":11,"riseRate":0.666667,"avgChangeRate":0.027739},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.103805}],"exchange":"NASDAQ","name":"PolyPid Ltd.","nameEN":"PolyPid Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PolyPid Ltd.(PYPD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest PolyPid Ltd.(PYPD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"PolyPid Ltd.,PYPD,PolyPid Ltd.股票,PolyPid Ltd.股票老虎,PolyPid Ltd.股票老虎国际,PolyPid Ltd.行情,PolyPid Ltd.股票行情,PolyPid Ltd.股价,PolyPid Ltd.股市,PolyPid Ltd.股票价格,PolyPid Ltd.股票交易,PolyPid Ltd.股票购买,PolyPid Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PolyPid Ltd.(PYPD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest PolyPid Ltd.(PYPD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction